Clinical trial
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
NCT02522481 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason™/SonoVue® in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
- Lead sponsor
- Bracco Diagnostics, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 24, 2015
- Completion date
- February 25, 2018
- Enrollment
- 175 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.